Marie H. Deventer

Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform

Lakshmi Vasudevan, Marthe M. Vandeputte, Marie H. Deventer et al. · Biochemical Pharmacology · 2020 · 51 citations · Full text

Drug Target, Biochemistry, Medicine +9

Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists

Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier et al. · Drug Testing and Analysis · 2022 · 39 citations · Full text

A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA

Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier et al. · Drug Testing and Analysis · 2022 · 30 citations · Full text

Structure–activity relationships of valine, <i>tert</i>-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA

Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin et al. · RSC Medicinal Chemistry · 2021 · 27 citations · Full text

Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists

Sophie A. M. Steinmüller, Julia Fender, Marie H. Deventer et al. · Angewandte Chemie International Edition · 2023 · 26 citations · Full text